• Drugs for Parasitic Infections. Treatment Guidelines from the Medical Letter. Vol 8 (Suppl), 2010. The Medical Letter, Inc., New Rochelle, NY.
• Schuster FL, Ramirez-Avila L. Current world status of Balantidium coli. Clin Microbiol Rev. 2008 Oct;21(4):626-38.
• Hill DR, Nash TE. Intestinal flagellate and ciliate infections. In Tropical Infectious Diseases, Principals, Pathogens, and Practice. Guerrant RL, Walker DH, Weller PF, Eds. Elsevier Churchill Livingston, Philadelphia, PA, 2006, pp. 993-4.
• Schuster FL, Visvesvara GS. Amebae and ciliated protozoa as causal agents of waterborne zoonotic disease. Vet Parasitol. 2004 Dec 9;126(1-2):91-120.
• Ferry T, Bouhour D, De Monbrison F, Laurent F, Dumouchel-Champagne H, Picot S, Piens MA, Granier P. Severe peritonitis due to Balantidium coli acquired in France. Eur J Clin Microbiol Infect Dis. 2004 May;23(5):393-5. Epub 2004 Apr 27.
• Anargyrou K, Petrikkos GL, Suller MT, Skiada A, Siakantaris MP, Osuntoyinbo RT, Pangalis G, Vaiopoulos G. Pulmonary Balantidium coli infection in a leukemic patient. Am J Hematol. 2003 Jul;73(3):180-3.
• Esteban JG, Aguirre C, Angles R, Ash LR, Mas-Coma S. Balantidiasis in Aymara children from the northern Bolivian altiplano. Am J Trop Med Hyg. 1998;59:922-7.
• Abaza H, El-Zayadi AR, Kabil SM, Rizk H. Nitazoxanide in the treatment of patients with intestinal protozoan and helminthic infections: a report on 546 patients in Egypt. Curr Ther Res 1998;59:116-21.

Back To Top